nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A preclinical and clinical review of aflibercept for the management of cancer
|
Gaya, Andrew |
|
2012 |
38 |
5 |
p. 484-493 10 p. |
artikel |
2 |
A role for maintenance therapy in managing sarcoma
|
Ray-Coquard, Isabelle |
|
2012 |
38 |
5 |
p. 368-378 11 p. |
artikel |
3 |
Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials
|
Adamowicz, Krzysztof |
|
2012 |
38 |
5 |
p. 554-558 5 p. |
artikel |
4 |
Biologic therapies in the metastatic colorectal cancer treatment continuum – Applying current evidence to clinical practice
|
Peeters, Marc |
|
2012 |
38 |
5 |
p. 397-406 10 p. |
artikel |
5 |
Cancer stem cells hypothesis and stem cells in head and neck cancers
|
Mannelli, Giuditta |
|
2012 |
38 |
5 |
p. 515-539 25 p. |
artikel |
6 |
Chemoprevention for breast cancer
|
Bozovic-Spasojevic, I. |
|
2012 |
38 |
5 |
p. 329-339 11 p. |
artikel |
7 |
Clinical and future applications of high intensity focused ultrasound in cancer
|
Al-Bataineh, Osama |
|
2012 |
38 |
5 |
p. 346-353 8 p. |
artikel |
8 |
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
|
Gnant, Michael |
|
2012 |
38 |
5 |
p. 407-415 9 p. |
artikel |
9 |
Docetaxel combined with targeted therapies in metastatic breast cancer
|
Cortes, Javier |
|
2012 |
38 |
5 |
p. 387-396 10 p. |
artikel |
10 |
Editorial Board
|
|
|
2012 |
38 |
5 |
p. IFC- 1 p. |
artikel |
11 |
EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
|
Soria, Jean-Charles |
|
2012 |
38 |
5 |
p. 416-430 15 p. |
artikel |
12 |
Electrochemotherapy of chest wall breast cancer recurrence
|
Sersa, Gregor |
|
2012 |
38 |
5 |
p. 379-386 8 p. |
artikel |
13 |
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
|
Soultati, Aspasia |
|
2012 |
38 |
5 |
p. 473-483 11 p. |
artikel |
14 |
Managing progressive disease in patients with GIST: Factors to consider besides acquired secondary tyrosine kinase inhibitor resistance
|
Patel, Shreyaskumar |
|
2012 |
38 |
5 |
p. 467-472 6 p. |
artikel |
15 |
New therapies in HER2-positive breast cancer: A major step towards a cure of the disease?
|
Awada, Ahmad |
|
2012 |
38 |
5 |
p. 494-504 11 p. |
artikel |
16 |
New treatment options for patients with metastatic castration-resistant prostate cancer
|
Higano, Celestia S. |
|
2012 |
38 |
5 |
p. 340-345 6 p. |
artikel |
17 |
Options on fertility preservation in female cancer patients
|
Rodriguez-Wallberg, Kenny A. |
|
2012 |
38 |
5 |
p. 354-361 8 p. |
artikel |
18 |
Pharmacogenetics of anti-estrogen treatment of breast cancer
|
Del Re, Marzia |
|
2012 |
38 |
5 |
p. 442-450 9 p. |
artikel |
19 |
Recommendations for the optimal management of early and advanced urothelial carcinoma
|
Castellano, Daniel |
|
2012 |
38 |
5 |
p. 431-441 11 p. |
artikel |
20 |
Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review
|
Baas, J.M. |
|
2012 |
38 |
5 |
p. 505-514 10 p. |
artikel |
21 |
State-of-the-art classification and multimodality treatment of malignant thymoma
|
Koppitz, Hannah |
|
2012 |
38 |
5 |
p. 540-548 9 p. |
artikel |
22 |
The ethnic divide in breast reconstruction: A review of the current literature and directions for future research
|
Nelson, Jonas A. |
|
2012 |
38 |
5 |
p. 362-367 6 p. |
artikel |
23 |
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
|
Roxburgh, C.S.D. |
|
2012 |
38 |
5 |
p. 451-466 16 p. |
artikel |
24 |
Uveal melanoma
|
Spagnolo, Francesco |
|
2012 |
38 |
5 |
p. 549-553 5 p. |
artikel |